Teikoku Pharma specializes in advanced transdermal drug delivery technologies, focusing on developing innovative therapies for pain management and other medical conditions. Their proprietary Hydrohesive® and Matrix® patch technologies are designed to enhance the delivery of both new and existing medications. The Hydrohesive® technology utilizes hydrophilic adhesives to ensure skin-friendly topical administration, allowing for daily drug delivery while minimizing side effects. In contrast, the Matrix® technology employs hydrophobic adhesives and rate-controlled membranes to extend drug delivery durations up to seven days, providing a sustained therapeutic effect.

The company’s flagship product, TPU-006, exemplifies their commitment to addressing unmet medical needs, particularly in the realm of non-opioid pain management. This investigational patch is designed to deliver dexmedetomidine for four days or longer, offering a continuous pain relief solution for post-surgical patients. By leveraging their advanced transdermal technologies, Teikoku Pharma aims to reduce reliance on opioids, thereby addressing the ongoing opioid crisis while improving patient outcomes through effective and convenient pain management solutions.

United States

Teikoku Pharma is a pharmaceutical company that specializes in drug development and healthcare solutions.

Teikoku Pharma

Company Details